• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾细胞癌与肥胖。

Renal Cell Cancer and Obesity.

机构信息

Department of Nephrology, Hypertension and Family Medicine, Medical University of Lodz, 113 Żeromskiego Street, 90-549 Lodz, Poland.

Department of Urology, Institute of Medical Sciences, Medical College of Rzeszow University, 35-055 Rzeszow, Poland.

出版信息

Int J Mol Sci. 2022 Mar 21;23(6):3404. doi: 10.3390/ijms23063404.

DOI:10.3390/ijms23063404
PMID:35328822
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8951303/
Abstract

Cancers are a frequent cause of morbidity and mortality. There are many risk factors for tumours, including advanced age, personal or family history of cancer, some types of viral infections, exposure to radiation and some chemicals, smoking and alcohol consumption, as well as obesity. Increasing evidence suggest the role of obesity in the initiation and progression of various cancers, including renal cell carcinoma. Since tumours require energy for their uncontrollable growth, it appears plausible that their initiation and development is associated with the dysregulation of cells metabolism. Thus, any state characterised by an intake of excessive energy and nutrients may favour the development of various cancers. There are many factors that promote the development of renal cell carcinoma, including hypoxia, inflammation, insulin resistance, excessive adipose tissue and adipokines and others. There are also many obesity-related alterations in genes expression, including DNA methylation, single nucleotide polymorphisms, histone modification and miRNAs that can promote renal carcinogenesis. This review focuses on the impact of obesity on the risk of renal cancers development, their aggressiveness and patients' survival.

摘要

癌症是发病率和死亡率的主要原因。肿瘤有许多风险因素,包括高龄、个人或家族癌症史、某些类型的病毒感染、辐射和某些化学物质暴露、吸烟和饮酒,以及肥胖。越来越多的证据表明肥胖在各种癌症(包括肾细胞癌)的发生和发展中的作用。由于肿瘤的生长是不可控的,因此需要能量,肿瘤的发生和发展似乎与细胞代谢的失调有关。因此,任何能量和营养摄入过多的状态都可能有利于各种癌症的发生。有许多因素可促进肾细胞癌的发展,包括缺氧、炎症、胰岛素抵抗、过多的脂肪组织和脂肪因子等。肥胖还会导致许多与基因表达相关的改变,包括 DNA 甲基化、单核苷酸多态性、组蛋白修饰和 miRNA,这些改变可促进肾肿瘤发生。本综述重点关注肥胖对肾细胞癌发展风险、侵袭性和患者生存的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b08/8951303/6f1796797048/ijms-23-03404-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b08/8951303/22495b3d7fe7/ijms-23-03404-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b08/8951303/f2c532658b74/ijms-23-03404-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b08/8951303/6f1796797048/ijms-23-03404-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b08/8951303/22495b3d7fe7/ijms-23-03404-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b08/8951303/f2c532658b74/ijms-23-03404-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b08/8951303/6f1796797048/ijms-23-03404-g003.jpg

相似文献

1
Renal Cell Cancer and Obesity.肾细胞癌与肥胖。
Int J Mol Sci. 2022 Mar 21;23(6):3404. doi: 10.3390/ijms23063404.
2
Transcriptomic signatures related to the obesity paradox in patients with clear cell renal cell carcinoma: a cohort study.与透明细胞肾细胞癌患者肥胖悖论相关的转录组特征:一项队列研究。
Lancet Oncol. 2020 Feb;21(2):283-293. doi: 10.1016/S1470-2045(19)30797-1. Epub 2019 Dec 20.
3
The Role of Metabolic Factors in Renal Cancers.代谢因素在肾脏肿瘤中的作用。
Int J Mol Sci. 2020 Sep 30;21(19):7246. doi: 10.3390/ijms21197246.
4
Heterogeneous miRNA-mRNA Regulatory Networks of Visceral and Subcutaneous Adipose Tissue in the Relationship Between Obesity and Renal Clear Cell Carcinoma.肥胖与肾透明细胞癌关系中外周和内脏脂肪组织中 miRNA-mRNA 调控网络的异质性。
Front Endocrinol (Lausanne). 2021 Sep 21;12:713357. doi: 10.3389/fendo.2021.713357. eCollection 2021.
5
Adipose tissue-to-breast cancer crosstalk: Comprehensive insights.脂肪组织与乳腺癌的相互作用:全面见解。
Biochim Biophys Acta Rev Cancer. 2022 Sep;1877(5):188800. doi: 10.1016/j.bbcan.2022.188800. Epub 2022 Sep 11.
6
The VHL-dependent regulation of microRNAs in renal cancer.VHL 依赖性调控肾癌中的 microRNAs。
BMC Med. 2010 Oct 21;8:64. doi: 10.1186/1741-7015-8-64.
7
MicroRNAs and other non-coding RNAs in adipose tissue and obesity: emerging roles as biomarkers and therapeutic targets.脂肪组织和肥胖中的 microRNAs 及其他非编码 RNA:作为生物标志物和治疗靶点的新作用。
Clin Sci (Lond). 2019 Jan 3;133(1):23-40. doi: 10.1042/CS20180890. Print 2019 Jan 15.
8
MicroRNAs and their target gene networks in renal cell carcinoma.微小 RNA 及其在肾细胞癌中的靶基因网络。
Biochem Biophys Res Commun. 2011 Feb 11;405(2):153-6. doi: 10.1016/j.bbrc.2011.01.019. Epub 2011 Jan 11.
9
Lipotoxicity as a trigger factor of renal disease.脂毒性作为肾脏疾病的触发因素。
J Nephrol. 2016 Oct;29(5):603-10. doi: 10.1007/s40620-016-0278-5. Epub 2016 Mar 8.
10
Association of Adipose Tissue and Adipokines with Development of Obesity-Induced Liver Cancer.脂肪组织和脂肪因子与肥胖相关性肝癌发展的相关性。
Int J Mol Sci. 2021 Feb 22;22(4):2163. doi: 10.3390/ijms22042163.

引用本文的文献

1
Associations of leucocyte subtypes and platelet parameters with kidney cancer risk in the UK Biobank cohort.英国生物银行队列中白细胞亚型和血小板参数与肾癌风险的关联。
J Inflamm (Lond). 2025 Aug 11;22(1):31. doi: 10.1186/s12950-025-00458-6.
2
Mechanisms underlying obesity-malignancy connection: a systematic narrative review.肥胖与恶性肿瘤关联的潜在机制:一项系统性叙述性综述
J Physiol Biochem. 2025 May 23. doi: 10.1007/s13105-025-01084-9.
3
The Role of Perirenal Adipose Tissue in Carcinogenesis-From Molecular Mechanism to Therapeutic Perspectives.

本文引用的文献

1
Leptin Augments Antitumor Immunity in Obesity by Repolarizing Tumor-Associated Macrophages.瘦素通过重极化肿瘤相关巨噬细胞增强肥胖中的抗肿瘤免疫。
J Immunol. 2021 Dec 15;207(12):3122-3130. doi: 10.4049/jimmunol.2001152. Epub 2021 Nov 12.
2
The Uniqueness of Clear Cell Renal Cell Carcinoma: Summary of the Process and Abnormality of Glucose Metabolism and Lipid Metabolism in ccRCC.透明细胞肾细胞癌的独特性:ccRCC中葡萄糖代谢和脂质代谢的过程及异常总结
Front Oncol. 2021 Sep 15;11:727778. doi: 10.3389/fonc.2021.727778. eCollection 2021.
3
Immune-based combinations for the treatment of metastatic renal cell carcinoma: a meta-analysis of randomised clinical trials.
肾周脂肪组织在致癌作用中的作用——从分子机制到治疗前景
Cancers (Basel). 2025 Mar 23;17(7):1077. doi: 10.3390/cancers17071077.
4
Prognostic factors and nomogram development for survival in renal cell carcinoma patients with multiple primary cancers: a retrospective study.肾细胞癌合并多原发癌患者生存的预后因素及列线图构建:一项回顾性研究
Transl Androl Urol. 2025 Mar 30;14(3):685-695. doi: 10.21037/tau-24-509. Epub 2025 Mar 26.
5
Metabolic Dysfunction-Associated Steatotic Liver Disease Is Associated with Increased Risk of Kidney Cancer: A Nationwide Study.代谢功能障碍相关脂肪性肝病与肾癌风险增加相关:一项全国性研究。
Cancers (Basel). 2024 Sep 15;16(18):3161. doi: 10.3390/cancers16183161.
6
Renal Cell Carcinoma With Tumor Thrombus: A Case Series in Puerto Rico.伴有肿瘤血栓的肾细胞癌:波多黎各的病例系列
Cureus. 2024 Apr 12;16(4):e58113. doi: 10.7759/cureus.58113. eCollection 2024 Apr.
7
Inhibition of Pancreatic Lipase by Flavonoid Derivatives: and Investigations.黄酮类衍生物对胰脂肪酶的抑制作用及研究
Adv Pharmacol Pharm Sci. 2024 Jan 24;2024:6655996. doi: 10.1155/2024/6655996. eCollection 2024.
8
Complement System and the Kidney: Its Role in Renal Diseases, Kidney Transplantation and Renal Cell Carcinoma.补体系统与肾脏:在肾脏疾病、肾移植和肾细胞癌中的作用。
Int J Mol Sci. 2023 Nov 20;24(22):16515. doi: 10.3390/ijms242216515.
9
The Association between Dietary Inflammatory Potential and Urologic Cancers: A Meta-analysis.膳食炎症潜能与泌尿系统癌症的关联:一项荟萃分析。
Adv Nutr. 2024 Jan;15(1):100124. doi: 10.1016/j.advnut.2023.09.012. Epub 2023 Nov 3.
10
Association of diabetes risk reduction diet with renal cancer risk in 101,755 participants: a prospective study.101755 名参与者中糖尿病风险降低饮食与肾癌风险的相关性:一项前瞻性研究。
J Transl Med. 2023 Oct 2;21(1):684. doi: 10.1186/s12967-023-04555-z.
免疫联合疗法治疗转移性肾细胞癌的疗效:一项随机临床试验的荟萃分析。
Eur J Cancer. 2021 Sep;154:120-127. doi: 10.1016/j.ejca.2021.06.015. Epub 2021 Jul 12.
4
Renal cell carcinoma (RCC): fatter is better? A review on the role of obesity in RCC.肾细胞癌(RCC):胖点更好?肥胖在肾细胞癌中作用的综述
Endocr Relat Cancer. 2021 Jun 2;28(7):R207-R216. doi: 10.1530/ERC-20-0457.
5
PPARs and Tumor Microenvironment: The Emerging Roles of the Metabolic Master Regulators in Tumor Stromal-Epithelial Crosstalk and Carcinogenesis.过氧化物酶体增殖物激活受体与肿瘤微环境:代谢主调控因子在肿瘤基质-上皮细胞相互作用及致癌过程中的新作用
Cancers (Basel). 2021 Apr 29;13(9):2153. doi: 10.3390/cancers13092153.
6
Identification of genes that correlate clear cell renal cell carcinoma and obesity and exhibit potential prognostic value.鉴定与透明细胞肾细胞癌和肥胖相关且具有潜在预后价值的基因。
Transl Androl Urol. 2021 Feb;10(2):680-691. doi: 10.21037/tau-20-891.
7
Blueprint for cancer research: Critical gaps and opportunities.癌症研究蓝图:关键差距与机遇
CA Cancer J Clin. 2021 Mar;71(2):107-139. doi: 10.3322/caac.21652. Epub 2020 Dec 16.
8
A Combined Effect of Expression Levels of Obesity-Related Genes and Clinical Factors on Cancer Survival Rate.肥胖相关基因表达水平与临床因素的综合作用对癌症生存率的影响。
Biomed Res Int. 2020 Nov 24;2020:8838676. doi: 10.1155/2020/8838676. eCollection 2020.
9
Tumor-Associated Macrophages: Protumoral Macrophages in Inflammatory Tumor Microenvironment.肿瘤相关巨噬细胞:炎症性肿瘤微环境中的促肿瘤巨噬细胞
Adv Pharm Bull. 2020 Sep;10(4):556-565. doi: 10.34172/apb.2020.066. Epub 2020 Aug 9.
10
Biological Support to Obesity Paradox in Renal Cell Carcinoma: A Review.生物支持在肾癌中的肥胖悖论:综述。
Urol Int. 2020;104(11-12):837-848. doi: 10.1159/000510245. Epub 2020 Aug 25.